Novo Nordisk: all 3 targets hit, coverage heading to the finish line

Novo Nordisk is at week 8 of a buy trade, up 9.5% from entry. All 3 statistical targets of the model have been hit ahead of schedule, but the coverage window is not yet closed — the final milestone is at week 10. The stop has been moved to breakeven, risk is zeroed out. The Healthcare sector is in a strong momentum phase, and the double bottom in the 42 area holds.